Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient
Gastroenterology
.
2017 Jan;152(1):300-301.
doi: 10.1053/j.gastro.2016.05.060.
Epub 2016 Nov 21.
Authors
Mhairi C Donnelly
1
,
Stuart N Imlach
2
,
Florence Abravanel
3
,
Sandeep Ramalingam
4
,
Ingolfur Johannessen
4
,
Juraj Petrik
2
,
Alistair R Fraser
5
,
John D M Campbell
5
,
Peter Bramley
6
,
Harry R Dalton
7
,
Peter C Hayes
1
,
Nassim Kamar
8
,
Kenneth J Simpson
9
Affiliations
1
Department of Hepatology and Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
2
Microbiology and Components Group, Scottish National Blood Transfusion Service Research, Development and Innovation, Edinburgh, UK.
3
Centre national de reference Hepatite E, Laboratoire de virology, CHU Toulouse Purpan, Institut Federatif de Biologie, Toulouse, France.
4
Department Of Virology, Royal Infirmary of Edinburgh, Edinburgh, UK.
5
Tissue and Cell Therapy Group, Scottish National Blood Transfusion Service Research, Development and Innovation, Edinburgh, UK.
6
Department of Gastroenterology, Forth Valley Royal, Stirling, UK.
7
Royal Cornwall Hospital, European Centre for Environment and Human Health, University of Exeter, Truro, UK.
8
Departement de Nephrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France.
9
Department Of Hepatology and Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
PMID:
27883881
DOI:
10.1053/j.gastro.2016.05.060
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents
Coinfection
HIV Infections
Hepatitis C
Humans
Sofosbuvir*
T-Lymphocytes
Viremia*
Substances
Antiviral Agents
Sofosbuvir